Effects of Prolonged Proton-Pump Inhibitor Use on Renal Dysfunction and Bone Fragility
Annals of Pharmacotherapy · 2025
DOI: 10.1177/10600280241273773 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Yianni Protopapadakis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Prisma Health Upstate, Greenville, SC, USA. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Osteoporosis, Renal Insufficiency, Chronic, Bone Diseases, Metabolic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Proton-pump inhibitor (PPI) use for management of gastroesophageal reflux disease (GERD) consists of a short-duration trial, according to guidelines. Long-term usage is appropriate under certain indications. Literature has increasingly documented an adverse effect profile of PPIs, including kidney disease and bone fragility.
Objective
To investigate the rate of occurrence of osteopenia, osteoporosis, and chronic kidney disease (CKD) in patients using PPI therapy for longer than the recommended trial period of 8 weeks.
Methods
Retrospective cohort analysis of a single-site primary care clinic. Patients aged 18 to 65 years with PPI prescriptions longer than 8 weeks were included. Information regarding PPI prescriptions, demographics, and medical diagnoses was collected.
Results
The search discovered 293 PPI-users and 1908 never-PPI-users. Demographics varied, with a P-value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Prisma Health Upstate, Greenville, SC, USA.
- School of Medicine-Greenville, University of South Carolina, Greenville, SC, USA.
- Department of Research and Biostatistics, Prisma Health Upstate, Greenville, SC, USA.
ORCID-Profile: Yianni Protopapadakis
Zitieren
APA
Protopapadakis, Y., Shuster, H., Bambach, A. B., Fitzgerald, S., Brayman, C., Ewing, J. A., & Blumer, M. (2025). Effects of Prolonged Proton-Pump Inhibitor Use on Renal Dysfunction and Bone Fragility. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280241273773
Vancouver
Protopapadakis Y, Shuster H, Bambach AB, Fitzgerald S, Brayman C, Ewing JA, et al. Effects of Prolonged Proton-Pump Inhibitor Use on Renal Dysfunction and Bone Fragility. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280241273773
BibTeX
@article{Protopapadakis2025,
author = {Protopapadakis, Yianni and Shuster, Hayden and Bambach, Austin B and Fitzgerald, Sean and Brayman, Christian and Ewing, Joseph A and Blumer, Mary},
title = {Effects of Prolonged Proton-Pump Inhibitor Use on Renal Dysfunction and Bone Fragility},
journal = {Annals of Pharmacotherapy},
year = {2025},
doi = {10.1177/10600280241273773}
}
EUVIMED